Cancer Medicine · 2015 · 43 citations · 34 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular Cell BiologyMolecular OncologyCancer Cell SignalingCancer MetabolismCancer TranscriptomicsColorectal CancerMetabolic ReprogrammingMetabolic Reprogramming In CancerCancer Signaling PathwaysColorectal Carcinogenesis PathophysiologyLuciferase Reporter AssaysLuciferase ReportersMicroarray AnalysisPromoter-reporter ConstructsTumor Metabolism
Colorectal cancer (CRC) is one of the most frequently occurring cancers with high morbidity and mortality worldwide. Amphiregulin (AREG), a member of the epidermal growth factor family and a rational target for CRC therapy, is essential for the three-dimensional structure of tumor formation. To clone the genes associated with increased AREG expression, we performed a cDNA microarray analysis in two CRC cell lines undergoing two-dimensional (2DC) and three-dimensional culture (3DC). Upregulated (>2.0-fold) and downregulated (<0.5-fold) genes in 3DC compared with 2DC were selected. Pathway analysis using DAVID based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway databases revealed a number of genes involved in glycolysis. In CRC cells, glucose elevated the expression of GLUT1 and AREG as well as the activity of the hypoxia-inducible factor 1 (HIF-1) luciferase reporter promoter. The suppression of AREG expression reduced the uptake of glucose and production of lactate. Luciferase assay identified a critical regulatory region for AREG expression between -130 and -180 bp upstream of the start site, which contained a carbohydrate response element (ChoRE). Max-like protein X (MLX) bound to ChoRE and enhanced the expression of AREG. Together these data suggest that AREG plays a pivotal role in the development of CRC through activation of the Warburg effect.
34
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine · 2009 · 3.9K citations · Full text
Medicine, Oncology, Pharmacology +17
Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 3K citations · Full text
Medicine, Oncology, Pharmacology +12
Burden of Gastrointestinal Disease in the United States: 2012 Update
Anne F. Peery, Evan S. Dellon, Jennifer L. Lund et al. · Gastroenterology · 2012 · 2K citations · Full text
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
Mahvash Zakikhani, Ryan J.O. Dowling, I. George Fantus et al. · Cancer Research · 2006 · 1K citations · Full text